Document is current
Any future updates will be listed below
-
Authors
Liu, Hengcong
Zhang, Juanjuan
Cai, Jun
Deng, Xiaowei
Peng, Cheng
Chen, Xinghui
Yang, Juan
Wu, Qianhui
Chen, Xinhua
Chen, Zhiyuan
Zheng, Wen
Viboud, Cécile
Zhang, Wenhong
Ajelli, Marco
Yu, Hongjie
-
Funding
Funding for this research was provided by:
the Key Program of the National Natural Science Foundation of China (82130093)
Collaboration for Leadership in Applied Health Research and Care - Greater Manchester (16/137/109)
Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response (20dz2260100)
- License Information
-
More Information
Article History
Received: 11 September 2021
Accepted: 6 January 2022
First Online: 31 January 2022
Declarations
:
: Not applicable
: Not applicable.
: H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. M.A. has received research funding from Seqirus. None of those research funding is related to COVID-19. All other authors report no competing interests.
